Related references
Note: Only part of the references are listed.1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one induces lung cancer cell apoptosis via the PI3K/Akt and ERK1/2 pathways
Jiangjiang Fan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Molecular characterization and expression analysis of big-belly seahorse (Hippocampus abdominalis) interleukin-10 and analysis of its potent anti-inflammatory properties in LPS-induced murine macrophage RAW 264.7 cells
M. D. Neranjan Tharuka et al.
GENE (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer
Chen-Yu Wang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2018)
Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines
Mira Y. Gökyildirim et al.
Oncotarget (2018)
Hydroxysafflor-Yellow A Induces Human Gastric Carcinoma BGC-823 Cell Apoptosis by Activating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
Li Liu et al.
MEDICAL SCIENCE MONITOR (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells
Alice Iezzi et al.
BMC CANCER (2018)
Resveratrol Attenuates Staphylococcus Aureus-Induced Monocyte Adhesion through Downregulating PDGFR/AP-1 Activation in Human Lung Epithelial Cells
I-Ta Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Response of Selenium and Selenogenome in Immune Tissues to LPS-Induced Inflammatory Reactions in Pigs
Lv-Hui Sun et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2017)
An Immunogram Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer
Takahiro Karasaki et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway
Longmei Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer
Nengli Yang et al.
ONCOLOGY REPORTS (2017)
Interleukin 32, inflammation and cancer
Jin Tae Hong et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Total glucosides of paeony inhibits lipopolysaccharide-induced proliferation, migration and invasion in androgen insensitive prostate cancer cells
Zhi-Hui Zhang et al.
PLOS ONE (2017)
Progress and prospects of early detection in lung cancer
Sean Blandin Knight et al.
OPEN BIOLOGY (2017)
Sulforaphane-cysteine-induced apoptosis via phosphorylated ERK 1/2-mediated maspin pathway in human non-small cell lung cancer cells
Kai Lin et al.
CELL DEATH DISCOVERY (2017)
The Role of E-Cadherin/β-Catenin in Hydroxysafflor Yellow A Inhibiting Adhesion, Invasion, Migration and Lung Metastasis of Hepatoma Cells
Long Ma et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer
Nikolaos Tsoukalas et al.
ANTICANCER RESEARCH (2017)
Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis
Colin Niaudet et al.
CELLULAR SIGNALLING (2017)
Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways
Okkeun Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Age and sex differences in immune response following LPS treatment in mice
Kyle Chiman Cai et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patients
Yan Han et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2016)
Effects of extracts and isolated compounds from safflower on some index of promoting blood circulation and regulating menstruation
Dong Yao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Lung cancer exosomes as drivers of epithelial mesenchymal transition
Mohammad A. Rahman et al.
ONCOTARGET (2016)
MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway
Qi Cao et al.
ONCOTARGET (2016)
Chemotherapy for Advanced-Stage Non-Small Cell Lung Cancer
Lingling Du et al.
CANCER JOURNAL (2015)
Second-Line Oral Chemotherapy (Lomustine, Cyclophosphamide, Etoposide) Versus Intravenous Therapy (Cyclophosphamide, Doxorubicin, and Vincristine) in Patients With Relapsed Small Cell Lung Cancer: A Randomized Phase II Study of GFPC 0501
Radj Gervais et al.
CLINICAL LUNG CANCER (2015)
Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice
Fangfang Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
Yu Sun et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Gram negative bacteria increase non-small cell lung cancer metastasis via toll-like receptor 4 activation and mitogen-activated protein kinase phosphorylation
Simon C. Chow et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Claudia Fumarola et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Molecular mechanisms underlying chronic inflammation-associated cancers
Yongzhong Wu et al.
CANCER LETTERS (2014)
Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats
Ren-ai Xu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
Katja Hattar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer
P. J. Vlachostergios et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Management of non-small-cell lung cancer: recent developments
Martin Reck et al.
LANCET (2013)
Effects of hydroxy safflower Yellow-A on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice
Xi Sheng-yan et al.
JOURNAL OF TRADITIONAL CHINESE MEDICINE (2012)
Infection, immunoregulation, and cancer
Graham A. W. Rook et al.
IMMUNOLOGICAL REVIEWS (2011)
Molecular networks for the study of TCM Pharmacology
Jing Zhao et al.
BRIEFINGS IN BIOINFORMATICS (2010)
Growth factors in tumor microenvironment
Xuejing Zhang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15
Xudong Liu et al.
MOLECULAR BIOLOGY REPORTS (2010)
Cancer and the tumor microenvironment: a review of an essential relationship
Flaubert Mbeunkui et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Natural products and drug discovery Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?
Hong-Fang Ji et al.
EMBO REPORTS (2009)
Class IA Phosphatidylinositol 3-Kinase Signaling in Non-small Cell Lung Cancer
Benjamin Solomon et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Targeting mTOR signaling in lung cancer
Marin Marinov et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
JM Tang et al.
LUNG CANCER (2006)
Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage
O David et al.
CLINICAL CANCER RESEARCH (2004)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Genotoxicity of several clinically used topoisomerase II inhibitors
G Boos et al.
TOXICOLOGY LETTERS (2000)
Share Paper
